Unleashing the Potential of Tau Oligomer Inhibition

Oligomerix® Vision

To discover novel and differentiated small molecules and biomarkers focused on tau oligomer inhibition for the disease-modifying treatment of Alzheimer’s disease and other related neurodegenerative diseases

Upcoming Events

Neurotech Investing and Partnering Conference 2019

Date & Time: Tuesday May 21, 10:45 AM
Session: Treatments for Alzheimer’s and Cognitive Disorders
Speaker: James Moe, CEO & President, Oligomerix, Inc.
Venue: Renaissance Waterfront Hotel, Boston, MA.

2019 BIO International Convention

Date, Time, & Room: Monday June 3, 3:45 PM, Theater 3
Title: In vivo validation of small molecule inhibitor of tau oligomer formation in htau mice
Speaker: James Moe, CEO & President, Oligomerix, Inc.
Venue: Pennsylvania Convention Center, Philadelphia, PA
Please visit us at: Booth 4270 Innovation Zone